Compare Abbott Laboratories (ABT) vs Global X Copper Miners ETF (COPX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Global X Copper Miners ETF — how do they compare? Abbott Laboratories trades at $95.13 (market cap $166.94B), while Global X Copper Miners ETF trades at $73.77. The key difference: Abbott Laboratories pays a 2.63% dividend while Global X Copper Miners ETF pays none, and Global X Copper Miners ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | COPX | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $136.62 | $95.70 |
52-Week Low | $82.57 | $42.75 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
COPX (Global X Copper Miners ETF) trades at $78.48, up 2.39% with a bullish technical signal despite mixed moving averages. The ETF provides diversified exposure to copper mining companies benefiting from AI-driven copper demand growth. Recent news highlights copper's structural deficit and AI infrastructure needs as key catalysts. Technical indicators show RSI_12 at 24.51 (buy signal) while ADX suggests strong trend momentum.
Outlook remains positive given copper's essential role in AI infrastructure and electrification trends. Key risks include copper price volatility and supply chain constraints. The ETF offers leveraged exposure to copper prices through mining equities, with support at $76 and resistance at $79-80 levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Global X Copper Miners ETF
COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.
Read more on COPX →
